A phase II trial of preoperative capecitabine plus irinotecan followed by combined modality capecitabine and radiation for locally advanced rectal cancer: Hoosier Oncology Group GI03-53
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 28 Apr 2011 Planned end date changed from 1 Jun 2009 to 1 May 2008 as reported by ClinicalTrials.gov.
- 22 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Jun 2009 as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.